ICOS Corp announced agreement to be acquired by Eli Lilly and Company
On Oct. 18, 2006, ICOS announced it had signed an agreement to be acquired by Eli Lilly and…
On Oct. 18, 2006, ICOS announced it had signed an agreement to be acquired by Eli Lilly and…
On Oct. 18, 2006, Trubion Pharmaceutical completed its IPO of 4,000,000 shares of common stock at $13.00 per…
On Oct. 16, 2006, the Cancer Genome Atlas program, created by National Cancer Institute and the National Human…
On Oct. 10, 2006, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for…
On Oct. 5, 2006, the Foundation for the National Institutes of Health, NIH, FDA, and the Pharmaceutical Research…
On Oct 2, 2006, National Cancer Institute researchers have linked specific genetic mutations to defects in cells that…
On Sept. 28, 2006, the Virginia Bioinformatics Institute (VBI) opened its new office complex in the National Capital…
On Sept. 27, 2006, the National Cancer Institute announced funding for a major component of its $104 million,…
On Sept. 26, 2006, the Allen Institute for Brain Science announced the completion of the groundbreaking Allen Brain…
On Sept. 18, 2006, Integrated DNA Technologies (IDT) announced the acquisition of RNA-TEC, based in Leuven, Belgium. The…
On Sept. 15, 2006, the Oklahoma Medical Research Foundation (OMRF) celebrated it’s 60th anniversary. More than 600 people…
On Sept. 8, 2006, BD (Becton, Dickinson) announced an agreement to acquire the 93.5% of the outstanding shares…
On Sept. 6, 2006, a report from the nation’s leading cancer organizations found that Americans’ risk of dying…
On Sept. 1, 2006, National Cancer Institute (NCI) researchers developed a new model for estimating the 5-year risk…
On Sept. 1, 2006, President Bush appointed John E. Niederhuber, M.D., to be the 13th director of the…
On Aug. 23, 2006, the Sandia Center for Integrated Nanotechnologies facility (CINT) was dedicated. Designed as a national…
On Aug. 14, 2006, National Cancer Institute (NCI) researchers announced they had found a unique pattern of activity…
On Aug. 11, 2006, Gilead Sciences announced that it had completed its acquisition of Corus Pharma for $365…
On Aug. 1, 2006, the Frances Langford Heart Center opened its doors bringing open-heart surgery and interventional cardiology…
On Jul. 20, 2006, Sandia and the University of New Mexico reported that experiments involving single-cell organisms in…
On Jul. 18, 2006, the Fred Hutchinson Business Alliance announced that the E. Donnall Thomas Medal of Achievement…
On Jul. 17, 2006, Eli Lilly and Company’s Gemzar was approved by the U.S. Food and Drug Administration (FDA) for…
On Jun. 30, 2006, Genentech drug Lucentisル (ranibizumab injection) was approved by the FDA for the treatment of…
On Jun. 29, 2006, researchers at the National Cancer Institute have identified a link between inherited and acquired…
On Jun. 29, 2006, the Immunization Practices Advisory Committee (ACIP) recommends second dose of varicella vaccine for children.
On Jun. 27, 2006, the U.S. Surgeon General released a report on the harmful health consequences of involuntary…
On Jun. 27, 2006, Johnsonᅠ &ᅠ Johnson announced it had acquired Pfizer Consumer Healthcare for $16.6 billion, which…
On Jun. 8, 2006, the FDA approved the vaccine Gardasil, which protects against persistent infection by the two…
On Jun. 7, 2006, gene profiling, a molecular technique that examines many genes simultaneously, can accurately distinguish between…
Washington BioEvolution illustrates life science companies and non-profit research organization in the State of Washington by the year…